{"id":4682,"date":"2016-10-13T05:44:06","date_gmt":"2016-10-13T09:44:06","guid":{"rendered":"https:\/\/medicarereport.org\/?p=4682"},"modified":"2016-10-12T15:46:34","modified_gmt":"2016-10-12T19:46:34","slug":"dea-opts-against-ban-on-herbal-supplement-kratom","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=4682","title":{"rendered":"DEA opts against ban on herbal supplement kratom"},"content":{"rendered":"<p>(By Alicia A. Cardwell\u00a0of Associated Press for ST<em>A<\/em>T)<\/p>\n<p><span class=\"big-cap\">W<\/span>ASHINGTON \u2014 The Drug Enforcement Administration has reversed a plan to <a href=\"https:\/\/www.statnews.com\/2016\/10\/05\/kratom-ban-dea-delay\/\" target=\"_blank\">temporarily ban<\/a><sup class=\"footnote\">1<\/sup> a plant that some users suggest could be an <a href=\"https:\/\/www.statnews.com\/2016\/09\/02\/kratom-devotees-fight-for-supplement\/\" target=\"_blank\">alternative<\/a><sup class=\"footnote\">2<\/sup> to powerful and addictive opioid painkillers. <a href=\"https:\/\/www.statnews.com\/2016\/10\/12\/kratom-dea-ban-opioids\/\" target=\"_blank\">Continue reading article here&#8230;&#8230;.<\/a><\/p>\n<p><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-4372\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png\" alt=\"stat-logo\" width=\"300\" height=\"32\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png 453w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<pre><strong>Notice<\/strong>: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(By Alicia A. Cardwell\u00a0of Associated Press for STAT) WASHINGTON \u2014 The Drug Enforcement Administration has reversed a plan to temporarily<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[19,15],"tags":[],"class_list":["post-4682","post","type-post","status-publish","format-standard","hentry","category-legal-actionscourt-decisions","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/4682","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4682"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/4682\/revisions"}],"predecessor-version":[{"id":4683,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/4682\/revisions\/4683"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4682"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4682"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4682"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}